colchicine and zd 6126
colchicine has been researched along with zd 6126 in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Blakey, DC; Chaplin, DJ; Davis, PD; Dougherty, GJ; Galbraith, SM; Hill, SA; Holder, AL; Naylor, MA; Nolan, J; Stratford, MR; Tozer, GM | 1 |
| Borsotti, P; Giavazzi, R; Imberti, B; Martinelli, M; Micheletti, G; Poli, M; Taraboletti, G | 1 |
| Borsotti, P; Dossi, R; Fiordaliso, F; Giavazzi, R; Martinelli, M; Micheletti, G; Ryan, AJ; Taraboletti, G | 1 |
| Ashton, S; D'Souza, RA; Partridge, EA; Patterson, AB; Roberts, DW; Ryan, A; Thurrell, CC; Wilson, Z | 1 |
| King, CD; Lenz, EM; McCormick, AD; McKillop, D; Phillips, PJ; Roberts, DW; Slamon, DL | 1 |
| Clarkson-Jones, J; D'Souza, RA; Lenz, EM; Partridge, EA; Roberts, DW; Smith, SM | 1 |
Other Studies
6 other study(ies) available for colchicine and zd 6126
| Article | Year |
|---|---|
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Cattle; Cell Survival; Colchicine; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Mice, SCID; Necrosis; Neoplasms, Experimental; Neovascularization, Pathologic; Organophosphorus Compounds; Pharyngeal Neoplasms; Prodrugs; Protein Binding; Tubulin; Xenograft Model Antitumor Assays | 2002 |
Vascular-targeting activity of ZD6126, a novel tubulin-binding agent.
Topics: Angiogenesis Inhibitors; Animals; Cells, Cultured; Colchicine; Cytoskeleton; Endothelium, Vascular; Humans; Lung; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Organophosphorus Compounds; Tubulin | 2003 |
Potential antagonism of tubulin-binding anticancer agents in combination therapies.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Colchicine; Cytoskeleton; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Endothelial Cells; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Fluorescence; Necrosis; Organophosphorus Compounds; Paclitaxel; Protein Binding; Taxoids; Tubulin; Umbilical Veins; Vincristine; Xenograft Model Antitumor Assays | 2005 |
Distribution of radioactivity and metabolite profiling in tumour and plasma following intravenous administration of a colchicine derivative (14C-ZD6126) to tumour-bearing mice.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Colchicine; Injections, Intravenous; Male; Mice; Mice, Nude; Neoplasms, Experimental; Organophosphorus Compounds; Tubulin Modulators | 2007 |
In vitro metabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes.
Topics: Adult; Aged; Alkaloids; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Colchicine; Female; Hepatocytes; Humans; In Vitro Techniques; Male; Mass Spectrometry; Microsomes, Liver; Middle Aged; Organophosphorus Compounds; Tubulin Modulators | 2007 |
Disposition and metabolism of the colchicine derivative [14C]-ZD6126 in rat and dog.
Topics: Aging; Animals; Bile; Carbon Radioisotopes; Colchicine; Dogs; Female; Injections, Intravenous; Male; Organ Specificity; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2008 |